Effect of Konjac-mannan in Individuals With Insulin-Resistance Syndrome
NCT ID: NCT03741686
Last Updated: 2018-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
11 participants
INTERVENTIONAL
1991-01-31
1999-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM
NCT03741660
The Effect of Konjac Grain in the Post-prandial Glycaemic Response of Healthy Subjects
NCT05850949
The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes
NCT02629263
Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes
NCT02806349
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
NCT01375803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Konjac-mannan
Konjac-mannan fiber-enriched biscuits with NCEP Step II metabolically controlled diet.
konjac glucomannan
Konjac-mannan fiber-enriched biscuits (0.5 g/412KJ \[100kcal\] of glucommanan)
Placebo
wheat bran fiber biscuits with NCEP Step II metabolically controlled diet.
wheat bran
Wheat bran (hard red wheat bran) fiber enriched biscuits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
konjac glucomannan
Konjac-mannan fiber-enriched biscuits (0.5 g/412KJ \[100kcal\] of glucommanan)
wheat bran
Wheat bran (hard red wheat bran) fiber enriched biscuits
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical absent of CHD
* BMI less than 30 kg/m2
* Presence of full insulin resistance syndrome
* Reduced HDL cholesterol
* Elevated serum triglycerides
* Moderate hypertension
Exclusion Criteria
* Regular alcohol consumption
* Family history of premature coronary heart disease
* Hypothyroidism
* Renal, hepatic or gastrointestinal disease
* Taking medications for hyperglycemia
* Taking medications for hyperlipidemia
* Taking medications for hypertension
45 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dicofarm
OTHER
University of Toronto, Toronto
UNKNOWN
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Konjac in Insulin Resistance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.